Mehdi Khashei | Pharmaceutical Analysis | Editorial Board Member

Prof. Mehdi Khashei | Pharmaceutical Analysis | Editorial Board Member

Isfahan University of Technology | Iran

Prof. Mehdi Khashei is a distinguished scholar in Industrial and Systems Engineering whose extensive academic and research contributions have positioned him as a leading expert in intelligent modeling, hybrid forecasting systems, and data-driven decision-making. He completed his academic journey with a strong mathematical and computational foundation, beginning with a Bachelor’s degree in Applied Mathematics and Computer Science from the University of Isfahan. Building on this analytical background, he pursued advanced studies at the Isfahan University of Technology, earning both his Master’s and Ph.D. in Industrial and Systems Engineering, where he focused on forecasting, analysis of industrial systems, and the integration of artificial intelligence into complex decision environments. His Post-Doctorate research at the same institution further advanced theoretical developments in Modeling Spaces Continuity, reinforcing his expertise in the intersection of systems theory, soft computing, and intelligent analytics.Throughout his academic career, Prof. Khashei has pioneered numerous innovative methodologies in the fields of time series forecasting, intelligent classification, hybrid modeling, and decision science. His research is particularly recognized for introducing discrete learning-based intelligent algorithms, reliability-based hybrid models, and advanced statistical-intelligent approaches for forecasting, classification, and optimization across diverse domains. His work spans energy systems, medicine, chemometrics, financial time series, predictive maintenance, load forecasting, and biomedical decision-making, demonstrating a unique capacity to bridge theory with real-world applications.Prof. Khashei has authored and co-authored an extensive portfolio of high-impact publications across leading international journals. His studies present cutting-edge solutions to challenges in artificial neural networks, fuzzy hybrid models, regression systems, clinical diagnostics, optimization strategies, and intelligent data preprocessing. His contributions have significantly shaped modern approaches to forecasting through hybridization frameworks such as series-parallel models, fuzzy-intelligent seasonal systems, and reliability-based methodologies. With groundbreaking insights into energy classification, breast cancer detection, heart disease diagnosis, and optimal financial turning point detection, his work continues to influence both academic research and applied industry practices.Prof. Mehdi Khashei is widely respected for his scientific rigor, interdisciplinary expertise, and commitment to advancing intelligent systems that enhance decision-making in complex, uncertain environments. His legacy is reflected not only in his prolific scholarly contributions but also in the transformative impact of his methodologies across engineering, computational intelligence, and data-driven industries.

Profile: Google Scholar

Featured Publications

Khashei, M., & Bijari, M. (2010). An artificial neural network (p, d, q) model for time series forecasting. Expert Systems with Applications, 37(1), 479‑489.

Khashei, M., & Bijari, M. (2011). A novel hybridization of artificial neural networks and ARIMA models for time series forecasting. Applied Soft Computing, 11(2), 2664‑2675.

Khashei, M., Bijari, M., & Ardali, G. A. R. (2009). Improvement of auto‑regressive integrated moving average models using fuzzy logic and artificial neural networks (ANNs). Neurocomputing, 72(4‑6), 956‑967.

Khashei, M., Hejazi, S. R., & Bijari, M. (2008). A new hybrid artificial neural networks and fuzzy regression model for time series forecasting. Fuzzy Sets and Systems, 159(7), 769‑786.

Hajirahimi, Z., & Khashei, M. (2019). Hybrid structures in time series modeling and forecasting: A review. Engineering Applications of Artificial Intelligence, 86, 83‑106.

Khashei, M., & Bijari, M. (2012). A new class of hybrid models for time series forecasting. Expert Systems with Applications, 39(4), 4344‑4357.

Khashei, M., Hamadani, A. Z., & Bijari, M. (2012). A novel hybrid classification model of artificial neural networks and multiple linear regression models. Expert Systems with Applications, 39(3), 2606‑2620.

Khashei, M., Bijari, M., & Ardali, G. A. R. (2012). Hybridization of autoregressive integrated moving average (ARIMA) with probabilistic neural networks (PNNs). Computers & Industrial Engineering, 63(1), 37‑45.

Khashei, M., & Hajirahimi, Z. (2019). A comparative study of series ARIMA/MLP hybrid models for stock price forecasting. Communications in Statistics – Simulation and Computation, 48(9), 2625‑2640.

Radhakrishnanand Pullapanthula | Pharmaceutical Analysis |

Prof. Dr. Radhakrishnanand Pullapanthula | Pharmaceutical Analysis | Best Researcher Award

National Institute of Pharmaceutical Education and Research | India

Prof. Dr. Radhakrishnanand Pullapanthula is a highly accomplished pharmaceutical scientist and analytical research leader with over two decades of distinguished experience in both industry and academia. A quality-minded professional, he has built a reputation for excellence in analytical compliance, regulatory affairs, and strategic development in the pharmaceutical sector. With a career spanning more than 24 years, including over 12 years in senior management positions, Dr. Pullapanthula has contributed significantly to analytical research and development, project leadership, and regulatory compliance within the framework of international standards such as cGMP, FDA, and ICH. His expertise lies in analytical method development, impurity profiling, physico-chemical characterization, and life cycle management of complex pharmaceutical products, including ANDA and NDA applications.Dr. Radhakrishnanand has been a driving force in setting up GMP-compliant analytical laboratories and implementing best practices for quality and regulatory adherence. His technical mastery covers LC-MS/MS, GC-MS/MS, ICP-MS, LC-Q-TOF-MS/MS, HPLC, GC, and IC techniques, enabling him to develop and validate advanced analytical methods for drug substances, formulations, excipients, food, and herbal products. His pioneering work in impurity profiling, degradation chemistry, and reference standard qualification has had a lasting impact on analytical R&D and pharmaceutical quality systems. As a leader, he has successfully coordinated the establishment of ISO 17025:2005 and ISO 17025:2017 certified laboratories, and played a key role in achieving NABL accreditation and ISO certification for analytical facilities at Daicel Chiral Technologies–India and United States Pharmacopeia.In addition to his industrial achievements, Dr. Radhakrishnanand has held prominent academic and administrative roles, serving as Registrar (In-Charge) and a board-level member in key scientific and innovation committees. His contributions extend to serving as an Expert Member on several national panels including the DST-Technology Development Board, ANRF-Life Sciences, NGCMA, and the Pharmaceutical Policy Committee of Tripura. As a Board of Director at the Atal Innovation Mission, NIPER-Guwahati, he has actively promoted innovation and research excellence in the pharmaceutical sciences. He currently manages and coordinates major projects such as the “Quality Assessment and Value Addition Centre for Herbal Industry in the North-Eastern States of India,” funded by the Ministry of Commerce under the TIES scheme, with a project worth exceeding twenty crores.

Profile: Google Scholar

Featured Publications

Rao, D. V. S., Radhakrishnanand, P., Suryanarayana, M. V., & Himabindu, V. (n.d.). A stability-indicating LC method for candesartan cilexetil. Chromatographia.

Kumari Rayala, V. V. S. P., Kandula, J. S., & Radhakrishnanand, P. (n.d.). Advances and challenges in the pharmacokinetics and bioanalysis of chiral drugs. Chirality.

Rao, D. V. S., & Radhakrishnanand, P. (n.d.). Stress degradation studies on dutasteride and development of a stability-indicating HPLC assay method for bulk drug and pharmaceutical dosage form. Chromatographia.

Kaja, R. K., Surendranath, K. V., Radhakrishnanand, P., Satish, J., & others. (n.d.). A stability-indicating LC method for deferasirox in bulk drugs and pharmaceutical dosage forms. Chromatographia.

Vishnuvardhan, C., Radhakrishnanand, P., Navalgund, S. G., Atcha, K. R., & others. (n.d.). RP-HPLC method for the simultaneous estimation of eight cardiovascular drugs. Chromatographia.

Rao, D. V. S., Radhakrishnanand, P., & Himabindu, V. (n.d.). Stress degradation studies on tadalafil and development of a validated stability-indicating LC assay for bulk drug and pharmaceutical dosage form. Chromatographia.

Subba Rao, D. V., Surendranath, K. V., Radhakrishnanand, P., & others. (n.d.). A stability-indicating LC method for vardenafil HCl. Chromatographia.